Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study
Authors:
- Danielle I. StanisicDSDanielle I. Stanisic
- James FinkJFJames Fink
- Johanna MayerJMJohanna Mayer
- Sarah CoghillSCSarah Coghill
- Letitia GoreLGLetitia Gore
- Xue Q. LiuXLXue Q. Liu
- Ibrahim El-DeebIEIbrahim El-Deeb
- Ingrid B. RodriguezIRIngrid B. Rodriguez
- Jessica PowellJPJessica Powell
- Nicole M. WillemsenNWNicole M. Willemsen
- Sai Lata DeSDSai Lata De
- Mei-Fong HoMHMei-Fong Ho
Open Access
- 8 October 2018
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 16 (1) , 184
Abstract
The continuing morbidity and mortality associated with infection with malaria parasites highlights the urgent need for a vaccine. The efficacy of sub-unit vaccines tested in clinical trials in malaria-endemic areas has thus far been disappointing, sparking renewed interest in the whole parasite vaccine approach. We previously showed that a chemically attenuated whole parasite asexual blood-stage vaccine induced CD4+ T cell-dependent protection against challenge with homologous and heterologous parasites in rodent models of malaria. In this current study, we evaluated the immunogenicity and safety of chemically attenuated asexual blood-stage Plasmodium falciparum (Pf) parasites in eight malaria-naïve human volunteers. Study participants received a single dose of 3 × 107 Pf pRBC that had been treated in vitro with the cyclopropylpyrolloindole analogue, tafuramycin-A. We demonstrate that Pf asexual blood-stage parasites that are completely attenuated are immunogenic, safe and well tolerated in malaria-naïve volunteers. Following vaccination with a single dose, species and strain transcending Plasmodium-specific T cell responses were induced in recipients. This included induction of Plasmodium-specific lymphoproliferative responses, T cells secreting the parasiticidal cytokines, IFN-γ and TNF, and CD3+CD45RO+ memory T cells. Pf-specific IgG was not detected. This is the first clinical study evaluating a whole parasite blood-stage malaria vaccine. Following administration of a single dose of completely attenuated Pf asexual blood-stage parasites, Plasmodium-specific T cell responses were induced while Pf-specific antibodies were not detected. These results support further evaluation of this chemically attenuated vaccine in humans. Trial registration: ACTRN12614000228684 . Registered 4 March 2014.Keywords
Funding Information
- National Health and Medical Research Council
- Atlantic Philanthropies
- The Merchant Foundation
This publication has 46 references indexed in Scilit:
- Epidemiology of subpatent Plasmodium falciparum infection: implications for detection of hotspots with imperfect diagnosticsMalaria Journal, 2013
- Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria ExposureNew England Journal of Medicine, 2013
- A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteersMalaria Journal, 2011
- Cellular Tumor Necrosis Factor, Gamma Interferon, and Interleukin-6 Responses as Correlates of Immunity and Risk of Clinical Plasmodium falciparum Malaria in Children from Papua New GuineaInfection and Immunity, 2009
- A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliVaccine, 2009
- Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western KenyaPLOS ONE, 2009
- Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challengeVaccine, 2008
- Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assaysMalaria Journal, 2008
- Chemical Attenuation of Plasmodium berghei Sporozoites Induces Sterile Immunity in MiceInfection and Immunity, 2008
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007